Loading...
Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study
BACKGROUND: Predialysis hemoglobin (Hb) may overestimate the true erithropoiesis-stimulating agents (ESA) requeriments. We tested whether predialysis Hb is a reliable predictor of the postdialysis level to better control ESA dosage, and evaluated the relation between ESA, Hb and cardiovascular event...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2012
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3444391/ https://ncbi.nlm.nih.gov/pubmed/22799577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-13-60 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|